Literature DB >> 72792

Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.

V Kratzsch, W R Kiessling.   

Abstract

The presence of measles cytotoxic (CT) and hemagglutination inhibition (HI) antibodies in 195 multiples sclerosis (MS) patients and 251 controls was tested. The measles virus Lu carrier cells labeled with 51Cr were exposed to serum specimens in the presence of complement in order to test the presence of CT antibody. The analysis of complement dependent CT antibodies against measles virus revealed significantly (P less than 0.01) higher titers in MS patients than in the control group. However, the measles HI test failed to show this difference. Measles CT titers greater than or equal to 1: 32 among MS patients occured in 54.9% and in 35.5% among the controls. In comparison with this the HI method revealed measles titers greater than or equal to 1:128 more often in the control group than in MS cases (27.9 and 17.9%, respectively). The presence of CT antibodies against measles virus in MS proves that these patients have a function defence mechanism to eliminate virus infected cells. The high measles antibody titer among MS patients could be due to recurrent antigenic stimulation caused measles virus persistency. Whether this virus persistency plays a role in MS can not be decided on the available data.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72792     DOI: 10.1007/BF00312814

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  On the evaluation of disability in multiple sclerosis.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1961-08       Impact factor: 9.910

2.  Clinical data from 418 MS patients in relation to the diagnosis. First experiences with an optical mark reader documentation system.

Authors:  S Poser; H Hauptvogel
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

3.  Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection.

Authors:  R Kibler; A Deller; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

4.  Persistent infection of cells in culture by measles virus. I. Development and characteristics of HeLa sublines persistently infected with complete virus.

Authors:  R Rustigian
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

5.  Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum.

Authors:  E Norrby; H Link; J E Olsson
Journal:  Arch Neurol       Date:  1974-04

6.  Antibody-mediated cytotoxicity after measles virus infection.

Authors:  R Kibler; V T Meulen
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

  7 in total
  2 in total

1.  Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virus.

Authors:  J Wikström; D W Meyer; K Eickhoff; G Ritter; S Poser; H J Bauer
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849

2.  Cytotoxic antibody to cells infected with measles virus in serum and cerebrospinal fluid of multiple sclerosis and control patients.

Authors:  N E Cremer; K P Johnson; G Fein; W H Likosky
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.